发明名称 |
Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
摘要 |
The present invention relates to the novel use of an adenosine aspartate product for the formulation of a drug intended to prevent the development of preneoplastic lesions and to reverse some types of cancer, particularly liver cancer, providing chemoprotection, preventing myelotoxic effects.
|
申请公布号 |
US8507459(B2) |
申请公布日期 |
2013.08.13 |
申请号 |
US20080676953 |
申请日期 |
2008.08.21 |
申请人 |
CHAGOYA-HAZAS VICTORIA-EUGENIA;HERNANDEZ MUNOZ ROLANDO-EFRAIN;VILLA-TREVINO SAUL;UNIVERSIDAD NACIONAL AUTONNOMA DE MEXICO |
发明人 |
CHAGOYA-HAZAS VICTORIA-EUGENIA;HERNANDEZ MUNOZ ROLANDO-EFRAIN;VILLA-TREVINO SAUL |
分类号 |
A61K31/70;A01N37/30;A61K31/205 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|